Merck & Co., Inc.

MRK
NYSE
Last Updated: 8/16/2022 7:03:48 AM
Price
90.6
Changes
-0.42
% Change
-0.46
Volume
6248974
52 Week
High
95.72
52 Week
Low
70.89
About Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Merck & Co., Inc. Company Details
CEO:   Mr. Kenneth Frazier
Country:   US
Industry:   Drug Manufacturers—General
Website:   https://www.merck.com
Exchange:   New York Stock Exchange
IPO\Launch Date:   1946-06-15
Merck & Co., Inc. Company Executive Details
  Ms. Cristal N. Downing
  Executive Vice President and Chief Communications & Public Affairs Officer
  Ms. Jennifer Mauer
  Vice President of Global Communications
  Michael W. Fleming
  Senior Vice President and Chief Ethics & Compliance Officer
  Mr. Peter Dannenbaum
  Vice President of Investor Relations
  Mr. David Michael Williams
  Chief Information & Digital Officer

Merck & Co., Inc. Latest News

Does Merck Finally Have The Fodder It Needs To Buy Seagen?


Seagen lost a royalty battle Friday, but SGEN stock jumped on the potential the rumored Merck acquisition could be looming. The post Does Merck Finally Have The Fodder It Needs To Buy Seagen?


Published on: 2022-08-12 17:09:24

Impact on Symbol / Company: MRK

View News

How the Inflation Reduction Act will affect Medicare


Yahoo Finance's Anjalee Khemlani breaks down the impacts the Inflation Reduction Act could have on Medicare enrollees should Congress pass it.


Published on: 2022-08-11 13:45:08

Impact on Symbol / Company: MRK

View News

10 defensive stocks that can also provide you with growth and dividends over the long term


The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.


Published on: 2022-08-10 10:05:00

Impact on Symbol / Company: MRK

View News

Get ready for more merger mania in pharma sector the rest of the year


Pfizer Inc.'s PFE, +0.24% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, +0.02% is the latest sign that cash-flush drug makers are ready to jump back into dealmaking.


Published on: 2022-08-09 14:43:00

Impact on Symbol / Company: MRK

View News

These 3 Dow Stocks Are Set to Soar in 2022's Second Half and Beyond


As the pandemic's impact continues to fade, several companies' situations are changing quickly.


Published on: 2022-08-08 10:45:00

Impact on Symbol / Company: MRK

View News

5 High-Flying U.S. Corporate Giants to Buy Despite Volatility


We have narrowed our search to five U.S. corporate giants. These are; XOM, CVX, AEP, MRK and SO.


Published on: 2022-08-08 09:47:34

Impact on Symbol / Company: MRK

View News

2 Healthcare Stocks You Can Buy and Hold for the Next Decade


Although they have moved in opposite directions this year, these two stocks should outperform for much of the next decade.


Published on: 2022-08-07 09:37:00

Impact on Symbol / Company: MRK

View News

Should You Buy Merck Stock After An Upbeat Q2?


Merck stock (NYSE: MRK) reported its Q2 results last week, with revenue and earnings comfortably above ours and the street estimates.


Published on: 2022-08-05 08:00:53

Impact on Symbol / Company: MRK

View News

Final Trades: Merck, Iron Mountain & more


The "Halftime Report" traders give their top picks to watch for the second half. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC Turn to CNBC TV for the latest stock market news and analysis.


Published on: 2022-08-04 14:54:42

Impact on Symbol / Company: MRK

View News

3 Pharma Stocks' Post-Earnings Price Moves


The health care sector is participating in the S&P's nascent rally, but pharmaceuticals AbbVie, Merck and Pfizer are holding up well relative to the market.


Published on: 2022-08-04 06:06:01

Impact on Symbol / Company: MRK

View News

Merck KGaA's adjusted earnings boosted by strong dollar


Germany's Merck KGaA saw adjusted earnings rise 13.1% in the second quarter as higher revenues from its biotech lab equipment and its chemicals for semiconductor production were further bolstered by a strong U.S. dollar.


Published on: 2022-08-04 01:03:00

Impact on Symbol / Company: MRK

View News

Merck: Strong Oncology Pipeline


Merck has an outstanding oncology portfolio that will drive growth in the foreseeable future. Strong fundamentals and cash position ensure Merck's growth will be well supported.


Published on: 2022-08-02 11:31:45

Impact on Symbol / Company: MRK

View News

Grow your Money

We helps you in understanding the science behind growing the money, which will help you diversify your funds as per your requirements and helps in achieving your retirement goals, children education, investment in property, business or any smart looking startup ventures

Services we Offer

We offer several services including expert recommendations & suggestions on buying ETF, Mutual Funds, Bonds, Debt securities, Equities, Property invesments and several others

Live Market Data

We provide you live market data for your analysis, review and looking out for quick buying opportunities to help you